• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Circulating tumor cells early predict prognosis of hepatocellular carcinoma treated with transarteri

Circulating tumor cells early predict prognosis of hepatocellular carcinoma treated with transarteri

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：cqjava
【摘 要】
：
Objective: To evaluate the potential utility of circulating tumor cells (CTCs) measurements in predicting prognosis of hepatocellular carcinoma (HCC) patients received trans arterial chemoembolization
【作 者】
：
Bo Zhou Guowei Yang Jianhua Wang 
【机 构】
：
Interventional Radiology, Fudan University Zhongshan Hospital
【出 处】
：
第十八届全国临床肿瘤学大会暨2015年CSCO学术年会
【发表日期】
：
2015年4期
【关键词】
：
hepatocellular carcinoma circulating tumor cells 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
　　Objective: To evaluate the potential utility of circulating tumor cells (CTCs) measurements in predicting prognosis of hepatocellular carcinoma (HCC) patients received trans arterial chemoembolization (TACE)treatments, including their differences in different vein sites and the immediate and delayed impact of TACE on CTCs.
其他文献
Clinicopathological features and the prognostic factors of colorectal neuroendocrine neoplasms (NENs
Objective: The World Health Organization classifies neuroendocrine neoplasms of the colon and rectum together as a single entity, but there is significant difference observed between them.
会议
Colorectal neuroendocrine neoplasmsPrognostic fac
The influence of marital status on stage at diagnosis and survival of patients with colorectal neuro
Objective: Research indicates an association between marital status and health but this link hasnt been thoroughly explored.Our goal was to examine the association of marital status on the survival ou
会议
colorectal neuroendocrine neoplasmsmarital statusprognostic analysis
The result of Phase 1b and phase 2 study of selective VEGFR inhibitor fruquintinib as 3+ line therap
Objective: Fruquintinib is a novel oral small molecule compound selectively inhibits vascular endothelial growth factor receptors (VEGFR)1, 2, and 3 with potent inhibitory effects on multiple human tu
会议
FruquintinibmCRCPFS
Prospective Randomized Phase Ⅱ Study of FOLFIRI versus FOLFOX7 in Advanced Gastric Adenocarcinoma: a
Objective: The purpose was to compare folinic acid, 5-fluorouracil (5-FU), and irinotecan (mFOLFIRI;arm A) with folinic acid, 5-FU, and oxaliplatin (mFOLFOX7;arm B) as first-line treatments in patient
会议
Advanced Gastric AdenocarcinomaFOLFIRIFOLFOX7
Safety and efficacy of first-line tepotinib (MSC2156119J)in a phase Ⅰb trial in Asian patients with
Objective: The overall prognosis of advanced hepatocellular cancer (HCC) remains poor, with c-Met abnormalities associated with a particularly poor prognosis.The highly selective c-Met inhibitor tepot
会议
hepatocellular cancer
Nomogram and Recursive Partitioning Analysis to Determine the Risk of Cancer-Specific Survival for P
Objective: Whether adjuvant chemoradiotherapy (ACRT) or chemotherapy (ACT) will benefit for stage Ⅱ or Ⅲ upper rectal cancer (URC) after radical surgery remains unclear.
会议
upper rectal canceradjuvant chemoradiotherapyadj
Metabolic tumor burden: a new promising way to reach precise personalised treatment in PDAC
Objective: Pancreatic cancer is currently one of the deadliest solid malignancies and pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer.
会议
PDACpancreatic ductal adenocarcinomaMTB
An open-label, randomized, multicenter study of S-1 vs Gemcitabine in patient with advanced pancreat
Objective: Gemcitabine (GEM) is a standard treatment in patients with advanced pancreatic cancer (PC).S-1 has shown a good efficacy and well safety in Japanese patients from previous studies and has b
会议
Advanced pancreatic cancerS-1GEM
First-line tepotinib (MSC2156119J), an oral c-Met inhibitor, versus sorafenib in Asian patients with
Background: HCC, a poor-prognosis disease for which the only approved drug is sorafenib, has a high unmet need.Factors associated with tumor aggressiveness in advanced HCC include c-Met amplification/
会议
HCC
Continuing single-agent capecitabin as maintenance therapy after induction of XELOX (or FOLFOX) in f
Objective: Colorectal cancer (CRC) is one of the most common malignant tumors.Most of advanced CRC will progress after first-line treatment;therefore, seeking an efficient and low toxic maintaining re
会议
Colorectal cancerMaintenance therapycapecitabine